Anonymous
Guest
Anonymous
Guest
To bad they don't hire people with experience...
they hired you and dumped you due to your "experience"
To bad they don't hire people with experience...
Par has done two generic deals that will add big time to earnings in the near future. The deals went unnoticed on Wall Street.Teva in effect gave par 3 drugs for "free" to avoid anti trust concerns for the ceph deal and one drug did over $1B in sales in 2010. BUY WITH BOTH FISTS
I guess on what ever planet you live, $20 million is considered "free"
change free to peanuts
$20 million is not peanuts. We paid fair value for the asset, but $20 million upfront is still significant.
it is less then peanuts, as teva was forced to unload for "free"
180 days exclusivity on a billion $ compound
any more freebees in the mill??????????
right we need a few more reps to leave but hey the jobs are few and far between and strativa reps are rusty from inactivity
Keep pumping the stock. It's 180 days of exclusivity that's shared with 6 other people.
right they paid 20m for 3 compounds and expect 40m in sales just from provigil in 2012
and you can continue to ignore a bargain, a buy with both fists opportunity
see you at $39
and they should finally confirm rumors to end that christmas holiday shutdown
Funny thing is the last 2 years the reps were asked to work on assignments as well. Take vacation but work as well.
No they are beating expectations acc to their stock analysts which is very good news for the par share price. Many par employees are wise to have prx shares in their 401 accounts
Many par employees are wise to have prx shares in their 401 accounts??? Which will still be worth nothing in 100 years. Better off having confeterate war bonds in your 401K. The south will rise again before Par ever does. Many Par employee's have their heads in a bong too. I am surprised that the company has not flatlined yet like the top management.
That was easy and the least we could do for the company. The holiday shutdown giveback was long overdue. Le Pore needs to get tough and transform par into a lean efficient machine as watson etc are eating our lunch as low cost generic producers squeeze par generics
GET READY FOR MORE GIVEBACKS
r